Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer

Clinical trial NCT06250036 · SUSPENDED

Trial details

NCT number: NCT06250036
Sponsor: Royal Marsden NHS Foundation Trust
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Gastric Adenocarcinoma MSI-H/dMMR Gastric Cancer MSI-H/dMMR Gastroesophageal-junction Cancer

Start date: 2025-02-20
Primary completion: 2027-03-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.